News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Halsey Drug (HDGC) Reports Results For First Quarter 2004



10/19/2005 5:11:24 PM

Halsey Drug Co., Inc. (OTC.BB:HDGC) today announced net income of $680,000 for the quarter ended March 31, 2004 compared to a net loss of $(10,575,000) for the same period in 2003. During the first quarter of 2004 the Company recorded product revenues of $628,000, and gains of $12,401,000 from debt restructuring and $1,754,000 from the divestment of certain non-revenue generating assets. Expenses for the first quarter of 2004 included, among other things, amortization of debt discount and private offering costs of $10,843,000 compared to $5,767,000 for the same period in 2003.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES